SEC Form 4 · accession 0001209191-17-030906
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Sullivan
Officer — Principal Accounting Officer
Period of report
Apr 3, 2017
Accepted (ET)
May 9, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 3, 2017 | A | 300 | $0.00 | A | 300 | I | By spouse |
| Common Stock | holding | — | — | — | 6,466 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F3 | $88.55 | Apr 3, 2017 | A | 1,200 | A | — | Apr 3, 2027 | Common Stock | 1,200 | 1,200 | I |
Explanation of responses
- F1Restricted stock units for common stock vests over a four-year period at a rate of 25% on 04/03/2018, 25% on 04/03/2019, 25% on 04/03/2020, and 25% on 04/03/2021.
- F2Equity grants held by the reporting person's spouse, who is employed by the issuer
- F3This option vests over a four-year period, at a rate of twenty-five percent (25%) on April 3, 2018 and in 36 equal monthly installments thereafter.